Interview with Tony Blair on vaccine distribution

The transcript discusses the strategic decisions made to invest in vaccine production capacity and the potential for sharing surplus vaccines with other countries. It highlights the importance of distributing vaccines to Africa, especially with the emergence of new strains. The need for rapid detection of new strains and the development of vaccines is emphasized, along with the importance of having the capacity to manufacture vaccines quickly.

What are the key considerations for developed countries when deciding to share surplus vaccines with developing countries?

How has the COVID-19 situation in Africa changed compared to the first wave of the disease?

What actions should be taken to detect new strains of COVID-19 more effectively?

In what ways can vaccine trials be shortened to respond to new pathogens?

What is the importance of having bioreactor capacity for vaccine manufacturing?